3451 - 3460 of 8404 Results
Title
Year
-
RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
-
OPENTitle: Alzheimer's Disease Alters Oligodendrocytic Glycolytic and Ketolytic Gene ExpressionJournal Name: The FASEB JournalPublisher: WileyVol: 35Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2021.35.s1.02461Best OA location URL: https://digitalcommons.wustl.edu/context/oa_4/article/3325/viewcontent/Alzheimer_s___Dementia___2021___Saito___Alzheimer_s_disease_alters_oligodendrocytic_glycolytic_and_ketolytic_gene.pdfCitation Count: 2
- Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations2021RESTRICTEDTitle: Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel RecommendationsJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 17Issue #:Start Page: 1589End Page: 1597Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s310605Best OA location URL: https://www.dovepress.com/getfile.php?fileID=69709Citation Count: 13
- Biomedical Research Must Change — But a Shift Toward Human-specific Research Methods Is Only Part of What Is Needed2021RESTRICTEDTitle: Biomedical Research Must Change — But a Shift Toward Human-specific Research Methods Is Only Part of What Is NeededJournal Name: Alternatives to Laboratory AnimalsPublisher: SAGE PublicationsVol: 49Issue #: 3Start Page: 69End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/02611929211030417Citation Count: 5
- Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo2021OPENTitle: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 2821End Page: 2840Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035Best OA location URL: http://www.cell.com/article/S1525001621002495/pdfCitation Count: 35
-
RESTRICTEDTitle: Challenges in the diagnosis of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 5Start Page: 385End Page: 397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00030-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185633Citation Count: 555
- Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles2021OPENTitle: Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesiclesJournal Name: CytotherapyPublisher: Elsevier BVVol: 23Issue #: 5Start Page: 373End Page: 380Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jcyt.2021.01.001Best OA location URL: http://www.isct-cytotherapy.org/article/S1465324921000013/pdfCitation Count: 179
-
RESTRICTEDTitle: Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatmentJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 124End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.027Best OA location URL: http://www.prd-journal.com/article/S1353802021001206/pdfCitation Count: 25
-
RESTRICTEDTitle: Excitotoxicity Revisited: Mitochondria on the Verge of a Nervous BreakdownJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 44Issue #: 5Start Page: 342End Page: 351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2021.01.001Best OA location URL: https://discovery.ucl.ac.uk/10122786/9/Duchen_071220_Plotegher%20et%20al._final.pdfCitation Count: 28
- Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins2021OPENTitle: Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxinsJournal Name: Redox BiologyPublisher: Elsevier BVVol: 41Issue #:Start Page: 101905End Page: 101905Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.redox.2021.101905Best OA location URL: https://doi.org/10.1016/j.redox.2021.101905Citation Count: 4